Prelude Capital Management, LLC Zimmer Biomet Holdings, Inc. Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$119.98 - $132.61 $437,207 - $483,230	3,644 New	3,644 $480,000
Q3 2023 Nov 14, 2023	BUY	$110.76 - $143.18 $571,078 - $738,236	5,156 New	5,156 $578,000
Q4 2022 Feb 14, 2023	BUY	$104.7 - $128.4 $157,887 - $193,627	1,508 Added 37.43%	5,537 $705,000
Q3 2022 Nov 14, 2022	BUY	$101.65 - $119.27 $141,903 - $166,500	1,396 Added 53.02%	4,029 $421,000
Q2 2022 Aug 15, 2022	SELL	$102.23 - $133.85 $491,521 - $643,550	-4,808 Reduced 64.61%	2,633 $277,000
Q1 2022 May 16, 2022	BUY	$108.42 - $129.58 $806,753 - $964,204	7,441 New	7,441 $952,000
Q3 2020 Nov 16, 2020	SELL	$113.59 - $141.68 $621,678 - $775,414	-5,473 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$87.02 - $133.4 $476,260 - $730,098	5,473 New	5,473 $653,000
Q1 2020 May 15, 2020	SELL	$78.28 - $155.73 $31,312 - $62,291	-400 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$127.4 - $146.83 $689,743 - $794,937	-5,414 Reduced 93.12%	400 $60,000
Q3 2019 Nov 14, 2019	BUY	$113.33 - $138.46 $658,900 - $805,006	5,814 New	5,814 $798,000

1,080

179M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.1B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.